Extrachromosomal DNA in cancer

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Extrachromosomal DNA (ecDNA) was historically considered rare but is now recognized as a significant factor in cancer.
• Modern imaging and computational methods have revealed ecDNA's crucial role in tumor biology and poor patient prognoses.

Purpose of the Study:

• To review recent advancements in understanding ecDNA biogenesis, maintenance, and transcriptional regulation.
• To highlight ecDNA's contribution to tumor heterogeneity, treatment resistance, and rapid cancer evolution.
• To identify key unanswered questions for developing ecDNA-targeted cancer therapies.

Main Methods:

• Review of current scientific literature on ecDNA in cancer.
• Analysis of modern imaging and computational techniques applied to ecDNA research.
• Synthesis of findings on ecDNA's impact on oncogene expression and tumor genome remodeling.

Main Results:

• Non-chromosomal inheritance of ecDNA leads to high oncogene copy numbers and intra-tumoral heterogeneity.
• Circular ecDNA architecture alters gene regulation, driving elevated oncogene expression.
• ecDNA hubs facilitate trans interactions, creating novel oncogenic transcription paradigms.
• ecDNA promotes rapid tumor evolution, contributing to treatment resistance and reduced survival.

Conclusions:

• ecDNA is a central driver of cancer pathogenesis across most cancer types.
• Understanding ecDNA's complex roles is essential for advancing cancer treatment strategies.
• Future research focusing on ecDNA biology will enable the development of targeted therapeutic approaches.